In discovery process comprises the early phases of research, which are designed to identify an investigational drug and perform primary tests in the lab. This first stage of the process takes almost three to six years. By the end, investigators hope to identify a capable drug aspirant to further study in the lab and in animal models, and then in people.

These advances offer great ability, but also add complexity to the R&D process. In order to ensure the safety and efficacy of personalized therapies that are used alongside diagnostics, clinical trial protocols must be modified and enhanced. This may need the use of additional procedures and resources, as well as new or innovative forms of data collection. Moreover, by their very nature, the patient population known to respond to targeted therapies is narrower, which makes patient recruitment more difficult.

For more details visit the website: http://drug-discovery.pharmaceuticalconferences.com/asiapacific/